The Journal of Membrane Biology

, Volume 247, Issue 5, pp 421–428 | Cite as

Different Incubation Times of Cells After Gene Electrotransfer in Fetal Bovine Serum Affect Cell Viability, but Not Transfection Efficiency

  • Masa Bosnjak
  • Beatriz Canals Lorente
  • Ziva Pogacar
  • Vesna Makovsek
  • Maja Cemazar
Article

Abstract

Electroporation as a delivery method is increasingly important in gene therapy, not only in vivo but also in in vitro experimental systems. Different applications of gene electrotransfer require high viability of cells and high transfection efficiency of gene electrotransfer. It was already demonstrated that the addition of fetal bovine serum (FBS) immediately after gene electrotransfer leads to improved cell survival and transfection efficiency. Therefore, the aim of the study was to determine whether prolonged incubation of cells in FBS, for more than standard 5 min, can lead to increased transfection efficiency and improved cell survival. Different murine melanoma and murine and human endothelial cell lines were transfected with plasmid encoding green fluorescent protein and then incubated for different periods of time in FBS (5–30 min). Transfection efficiency was determined by flow cytometry and fluorescence microscopy and cell survival by cell viability assay. Prolonged incubation of cells in FBS after gene electrotransfer had varying effect on cell survival, which was decreased in melanoma cell lines B16F1 and B16F10, minimally affected in SVEC4-10 and HUVEC cells and increased in 2H11 cell at 30 min of incubation time in FBS. On the other hand, transfection efficiency of gene electrotransfer was not affected by long incubation of cell in FBS, regardless of the cell line used. The results of our study emphasize the importance of optimization of gene electrotransfer protocol for particular cells and specific purposes of gene electrotransfer, taking into account the importance of transfection efficiency and cell survival.

Keywords

Gene electrotransfer Fetal bovine serum Melanoma cells Endothelial cells Cell survival Transfection efficiency 

References

  1. Bosnjak M, Prosen L, Dolinsek T, Blagus T, Markelc B, Cemazar M, Bouquet C, Sersa G (2013) Biological properties of melanoma and endothelial cells after plasmid AMEP gene electrotransfer depend on integrin quantity on cells. J Membr Biol 246:803–819CrossRefPubMedGoogle Scholar
  2. Cemazar M, Jarm T, Miklavcic D, Lebar AM, Ihan A, Kopitar NA, Sersa G (1998a) Effect of electric-field intensity on electropermeabilization and electrosensitivity of various tumor-cell lines in vitro. Electro- and Magnetobiol 17:263–272CrossRefGoogle Scholar
  3. Cemazar M, Miklavcic D, Sersa G (1998b) Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res 89:328–333CrossRefPubMedGoogle Scholar
  4. Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie J (2008) Electrochemotherapy in veterinary oncology. J Vet Intern Med 22:826–831CrossRefPubMedGoogle Scholar
  5. Cemazar M, Jarm T, Sersa G (2010) Cancer electrogene therapy with interleukin-12. Curr Gene Ther 10:300–311CrossRefPubMedGoogle Scholar
  6. Chabot S, Pelofy S, Paganin-Gioanni A, Teissie J, Golzio M (2011) Electrotransfer of RNAi-based oligonucleotides for oncology. Anticancer Res 31:4083–4089PubMedGoogle Scholar
  7. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL, Heller R (2008) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26:5896–5903PubMedCentralCrossRefPubMedGoogle Scholar
  8. Delteil C, Teissie J, Rols MP (2000) Effect of serum on in vitro electrically mediated gene delivery and expression in mammalian cells. Biochim Biophys Acta 1467:362–368CrossRefPubMedGoogle Scholar
  9. Dolinsek T, Markelc B, Sersa G, Coer A, Stimac M, Lavrencak J, Brozic A, Kranjc S, Cemazar M (2013) Multiple delivery of siRNA against endoglin into murine mammary adenocarcinoma prevents angiogenesis and delays tumor growth. PLoS One 8:e58723PubMedCentralCrossRefPubMedGoogle Scholar
  10. Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, Mali B, Jarm T, Pavliha D, Marcan M, Gasljevic G, Gorjup V, Music M, Vavpotic TP, Cemazar M, Snoj M, Sersa G (2011) Electrochemotherapy: a new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 10:475–485PubMedCentralPubMedGoogle Scholar
  11. Escoffre JM, Portet T, Wasungu L, Teissie J, Dean D, Rols MP (2009) What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues. Mol Biotechnol 41:286–295CrossRefPubMedGoogle Scholar
  12. Escoffre JM, Portet T, Favard C, Teissie J, Dean DS, Rols MP (2011) Electromediated formation of DNA complexes with cell membranes and its consequences for gene delivery. Biochim Biophys Acta 1808:1538–1543CrossRefPubMedGoogle Scholar
  13. Ferreira E, Potier E, Logeart-Avramoglou D, Salomskaite-Davalgiene S, Mir LM, Petite H (2008) Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Ther 15:537–544CrossRefPubMedGoogle Scholar
  14. Golzio M, Rols MP, Teissie J (2004) In vitro and in vivo electric field-mediated permeabilization, gene transfer, and expression. Methods 33:126–135CrossRefPubMedGoogle Scholar
  15. Heller LC, Heller R (2010) Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 10:312–317CrossRefPubMedGoogle Scholar
  16. Jaroszeski MJ, Gilbert R, Nicolau C, Heller R (1999) In vivo gene delivery by electroporation. Adv Drug Deliv Rev 35:131–137CrossRefPubMedGoogle Scholar
  17. Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R (2000) Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 11:201–208CrossRefPubMedGoogle Scholar
  18. Liew A, Andre FM, Lesueur LL, De Menorval MA, O’Brien T, Mir LM (2013) Robust, efficient, and practical electrogene transfer method for human mesenchymal stem cells using square electric pulses. Hum Gene Ther Methods 24:289–297PubMedCentralCrossRefPubMedGoogle Scholar
  19. Linnert M, Iversen HK, Gehl J (2012) Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy. Radiol Oncol 46:271–278PubMedCentralCrossRefPubMedGoogle Scholar
  20. Low L, Mander A, McCann K, Dearnaley D, Tjelle T, Mathiesen I, Stevenson F, Ottensmeier CH (2009) DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther 20:1269–1278CrossRefPubMedGoogle Scholar
  21. Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D (2013) Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. Eur J Surg Oncol 39:4–16CrossRefPubMedGoogle Scholar
  22. Markelc B, Tevz G, Cemazar M, Kranjc S, Lavrencak J, Zegura B, Teissie J, Sersa G (2012) Muscle gene electrotransfer is increased by the antioxidant tempol in mice. Gene Ther 19:312–320PubMedCentralCrossRefPubMedGoogle Scholar
  23. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D, Pavlovic I, Paulin-Kosir SM, Cemazar M, Morsli N, Rudolf Z, Robert C, O’Sullivan GC, Mir LM (2006) Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Suppl 4:3–13CrossRefGoogle Scholar
  24. Miklavcic D, Sersa G, Brecelj E, Gehl J, Soden D, Bianchi G, Ruggieri P, Rossi CR, Campana LG, Jarm T (2012) Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 50:1213–1225PubMedCentralCrossRefPubMedGoogle Scholar
  25. Mir LM, Banoun H, Paoletti C (1988) Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: Direct access to the cytosol. Exp Cell Res 175:15–25CrossRefPubMedGoogle Scholar
  26. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C (1991) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27:68–72CrossRefPubMedGoogle Scholar
  27. Neumann E, Rosenheck K (1972) Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 10:279–290CrossRefPubMedGoogle Scholar
  28. O′Hare MJ, Ormerod MG, Imrie PR, Peacock JH, Asche W (1989). Electropermeabilization and Electrosensitivity of Different Types of Mammalian Cells Electroporation and electrofusion in cell biology. E. S. A. E. J. C. A. Neumann. New York, Plenum PressGoogle Scholar
  29. Pavlin D, Cemazar M, Cor A, Sersa G, Pogacnik A, Tozon N (2011) Electrogene therapy with interleukin-12 in canine mast cell tumors. Radiol Oncol 45:31–39PubMedCentralCrossRefPubMedGoogle Scholar
  30. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J (1998) In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16:168–171CrossRefPubMedGoogle Scholar
  31. Rosazza C, Phez E, Escoffre JM, Cezanne L, Zumbusch A, Rols MP (2012) Cholesterol implications in plasmid DNA electrotransfer: Evidence for the involvement of endocytotic pathways. Int J Pharm 423:134–143CrossRefPubMedGoogle Scholar
  32. Rosazza C, Buntz A, Riess T, Woll D, Zumbusch A, Rols MP (2013) Intracellular tracking of single-plasmid DNA particles after delivery by electroporation. Mol Ther 21:2217–2226PubMedCentralCrossRefPubMedGoogle Scholar
  33. Sardesai NY, Weiner DB (2011) Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 23:421–429PubMedCentralCrossRefPubMedGoogle Scholar
  34. Sedlar A, Dolinsek T, Markelc B, Prosen L, Kranjc S, Bosnjak M, Blagus T, Cemazar M, Sersa G (2012) Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol 46:302–311PubMedCentralCrossRefPubMedGoogle Scholar
  35. Sersa G, Cemazar M, Miklavcic D (1995) Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 55:3450–3455PubMedGoogle Scholar
  36. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z (2000) Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 6:863–867PubMedGoogle Scholar
  37. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M (2008) Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 34:232–240CrossRefPubMedGoogle Scholar
  38. Spanggaard I, Snoj M, Cavalcanti A, Bouquet C, Sersa G, Robert C, Cemazar M, Dam E, Vasseur B, Attali P, Mir LM, Gehl J (2013) Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Hum Gene Ther Clin Dev 24:99–107CrossRefPubMedGoogle Scholar
  39. Teissie J, Golzio M, Rols MP (2005) Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta 1724:270–280CrossRefPubMedGoogle Scholar
  40. Teissie J, Escoffre JM, Paganin A, Chabot S, Bellard E, Wasungu L, Rols MP, Golzio M (2012) Drug delivery by electropulsation: Recent developments in oncology. Int J Pharm 423:3–6CrossRefPubMedGoogle Scholar
  41. Tesic N, Cemazar M (2013) In vitro targeted gene electrotransfer to endothelial cells with plasmid DNA containing human endothelin-1 promoter. J Membr Biol 246:783–791CrossRefPubMedGoogle Scholar
  42. Testori A, Tosti G, Martinoli C, Spadola G, Cataldo F, Verrecchia F, Baldini F, Mosconi M, Soteldo J, Tedeschi I, Passoni C, Pari C, Di Pietro A, Ferrucci PF (2010) Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach. Dermatol Ther 23:651–661CrossRefPubMedGoogle Scholar
  43. Tozon N, Pavlin D, Sersa G, Dolinsek T, Cemazar M (2013). Electrochemotherapy with intravenous bleomycin injection: an observational study in superficial squamous cell carcinoma in cats, J Feline Med SurgGoogle Scholar
  44. Vidic S, Markelc B, Sersa G, Coer A, Kamensek U, Tevz G, Kranjc S, Cemazar M (2010) MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. Cancer Gene Ther 17:409–419CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Masa Bosnjak
    • 1
  • Beatriz Canals Lorente
    • 1
  • Ziva Pogacar
    • 1
  • Vesna Makovsek
    • 1
  • Maja Cemazar
    • 1
    • 2
  1. 1.Department of Experimental OncologyInstitute of Oncology LjubljanaLjubljanaSlovenia
  2. 2.Faculty of Health SciencesUniversity of PrimorskaIzolaSlovenia

Personalised recommendations